Literature DB >> 2477454

Analysis of an immunodominant region of infectious bronchitis virus.

J G Kusters1, E J Jager, J A Lenstra, G Koch, W P Posthumus, R H Meloen, B A van der Zeijst.   

Abstract

We analyzed the antigenic fine-structure of an immunodominant region in the peplomer protein of infectious bronchitis virus. This region near the N-terminus of the S2 subunit is recognized by polyclonal antisera and by the majority of mAb that cross-react with denatured protein. Despite their involvement in neutralization, epitopes in this region were conserved in different serotypes. Epitopes of four mAb and two chicken antisera were localized by using prokaryotic expression of cDNA fragments, and overlapping peptides with lengths increasing from 3 to 12 residues (PEPSCAN). We found overlapping epitopes with lengths of 6, 9, 11, and more than 17 residues. The results indicate that the expression products are antigenically equivalent to denatured protein fragments. This suggests a general strategy for the localization of sequential epitopes in large proteins. We propose that the immunodominance of the N-terminal region of S2 is explained by features of the protein structure. Presumably, this region is a protruding protein segment of about 20 residues with a high local mobility, as indicated by the antigenicity of the peptides. The conservation of the sequence points to an involvement in a molecular recognition process during infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477454

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus.

Authors:  W P Posthumus; J A Lenstra; W M Schaaper; A P van Nieuwstadt; L Enjuanes; R H Meloen
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

2.  Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping.

Authors:  P N Redlich; P D Hoeprich; C B Colby; S E Grossberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  Analysis of the serotype-specific epitopes of avian infectious bronchitis virus strains Ark99 and Mass41.

Authors:  W Jia; X Wang; C R Parrish; S A Naqi
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

4.  Infectious bronchitis virus S2 gene sequence variability may affect S1 subunit specific antibody binding.

Authors:  S A Callison; M W Jackwood; D A Hilt
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

5.  Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus.

Authors:  A M Boots; J G Kusters; J M van Noort; K A Zwaagstra; E Rijke; B A van der Zeijst; E J Hensen
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

6.  Spike gene analysis of the DE072 strain of infectious bronchitis virus: origin and evolution.

Authors:  C W Lee; M W Jackwood
Journal:  Virus Genes       Date:  2001-01       Impact factor: 2.332

7.  MHC class II-restricted T-cell hybridomas recognizing the nucleocapsid protein of avian coronavirus IBV.

Authors:  A M Boots; M J Van Lierop; J G Kusters; P J Van Kooten; B A Van der Zeijst; E J Hensen
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

8.  Identification of a novel linear B-cell epitope in the M protein of avian infectious bronchitis coronaviruses.

Authors:  Junji Xing; Shengwang Liu; Zongxi Han; Yuhao Shao; Huixin Li; Xiangang Kong
Journal:  J Microbiol       Date:  2009-10-24       Impact factor: 3.422

9.  The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens.

Authors:  J Ignjatovic; L Galli
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 10.  The next-generation coronavirus diagnostic techniques with particular emphasis on the SARS-CoV-2.

Authors:  Maged G Hemida
Journal:  J Med Virol       Date:  2021-03-26       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.